33
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Central Nervous System Monoamine Neurotransmitter Turnover in Primary and Obesity-Related Human Hypertension

, , , , , , , & show all
Pages 577-590 | Published online: 03 Jul 2009

References

  • Esler M., Lambert G., Jennings G. Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens. 1990; 8(Suppl7)S53–S57
  • Eide I., Kolloch R., De Quattro V., Miano L., Dugger R., Van der Meulen J. Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension 1979; 1: 255–260
  • Chalmers J., Pilowsky P. Brainstem and bulbospinal neurotransmitter system in the control of blood pressure. J Hypertens. 1991; 9: 675–694
  • Dahlstrom A., Fuxe K. Evidence for existence of monoamine-containing neurones in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurones. Acta Physiol Scand. 1964; 232(Suppl)1–55
  • Foote S. L., Bloom F. E., Aston-Jones G. Nucleus coeruleus: New evidence of anatomical and physiological specificity. Physiol Rev. 1983; 63: 844–914
  • Van Huysse J. W., Bealer S. L. Central nervous system norepinephrine release, hypotension and hyperosmolality in conscious rats. Am J Physiol. 1991; 260: R1071–1076
  • Huangfu D., Koshiya N., Guyenet P. A5 noradrenergic unit activity and sympathetic nerve discharge in rats. Am J Physiol. 1991; 261: R393–R402
  • Huangfu D., Hwang L. J., Riley T. A., Guyenet P. Splanchnic nerve responses to A5 area stimulation in rats. Am J Physiol. 1992; 263: R437–R446, (Regulatory Integrative Comp Physiol. 32)
  • Singewald N., Philippu A. Catecholamine release in the locus coeruleus is modified by experimentally induced changes in haemodynamics. Naunyn Schmiedeberg's Arch Pharmacol. 1993; 347: 21–27
  • Strack A. M., Sawyer W. B., Hughes J. H., Platt K. B., Loewy A. D. A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res. 1989; 491: 156–162
  • Ferrier C., Jennings G. L., Eisenhofer G., Lamben G., Cox H., Kalff V., Kelly M., Esler M. D. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens. 1993; 11: 1217–1227
  • Lambert G. W., Ferrier C., Kaye D., Cox H. S., Turner A. G., Jennings G. L., Esler M. D. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. Blood Pressure 1994; 3: 55–66
  • Ross C. A., Ruggiero D. A., Morrison S. F. Rostralventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing Cl adrenaline neurons. J Compar Neural. 1984; 228: 168–185
  • Reis D. J. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting on imidazoline receptors. J Cardiovasc Pharmacol. 1996; 27(Suppl.3)S11–S18
  • Lamben G. W., Ferrier C., Kaye D. M., Jennings G. L., Kalff V., Kelly M. J., Cox H. S., Turner A. G., Esler M. D. Central nervous system norepinephrine turnover in essential hypertension. The Imidazoline Receptor. Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine, D. J. Reis. Annals of the New York Academy of Sciences. 1995; 763: 679–694
  • Lambert G. W., Kaye D. M., Lefkovits J., Jennings G. L., Turner A. G., Cox H. S., Esler M. D. Central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 1995; 92: 1813–1818
  • Patel K. P., Zhang P. L., Krukoff T. L. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol. 1993; 265: R923–R928
  • Kaye D. M., Lefkovits J., Jennings G. L., Bergin P., Broughton A., Esler M. D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiology 1995; 26: 1257–1263
  • Manolis A. J., Olympios C., Sifaki M., Handanis S., Bresnahan M., Gavras I., Gavras H. Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension 1995; 26: 719–724
  • Glowinski J., Kopin I. J., Axelrod J. Metabolism of [3H] epinephrine in the rat brain. J Neurochem. 1965; 12: 25–30
  • Kaye D. M., Lambert G. W., Lefkovits J., Morris M., Jennings G. L., Esler M. D. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994; 23: 570–578
  • Elam M., Svensson T. H., Thoren P. Differentiated cardiovascular afferent regulation of the locus coeruleus and sympathetic nerves. Brain Res. 1985; 358: 77–84
  • Lambert G. W., Kaye D. M., Cox H. S., Vaz M., Turner A. G., Jennings G. L., Esler M. D. Regional 5-hydroxyindoleacetic acid production in humans. Life Sciences 1995; 57: 255–267
  • Rohner-Jeanrenaud F., Jeanrenard B. Obesity, Leptin and the brain. New Engl J Med. 1996; 334: 324–325

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.